A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors (PFH2)
The purpose of this study is to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants will get materials in the mail about their health, survivorship, and smoking. Some participants will also be invited to use a website. The goal of the study is to see which is a better way to get information about health issues, survivorship, and smoking.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Partnership for Health: A Web-Based Smoking Intervention For Cancer Survivors|
- The primary outcome is smoking cessation [ Time Frame: 15 months post BL ] [ Designated as safety issue: No ]
- Secondary outcome: cost-effectiveness, intervention dose delivered, reach, impact, quit attempts, motivation to quit, and use of pharmacotherapy [ Time Frame: 15 months post BL ] [ Designated as safety issue: No ]
|Study Start Date:||September 2005|
|Estimated Study Completion Date:||July 2013|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
Experimental: Web site access
Other: Web Intervention
Receives pharmacotherapy and access to an interactive Web site (Web condition). The Web site will offer tailored intervention messages and strategies in an interactive format that is much less labor-intensive and costly than the prior PFH peer telephone counseling intervention.
Active Comparator: print materials
Receives tailored print materials and pharmacotherapy (Materials condition)
Behavioral: print materials
tailored print materials designed to aid in smoking reduction and cessation
The proposed study is a randomized controlled trial with two groups. It is designed to demonstrate the efficacy and cost-effectiveness of a Web-based format of the PFH intervention, compared to a written Materials control condition. The study will be conducted among childhood and young adult cancer survivors who smoke at four survivor clinics. Participants in both conditions will receive access to pharmacotherapy at no cost. Participants in the Web condition will receive access to an interactive Web site that focuses on survivorship, health, and smoking.
Participants in the Web condition will receive access to an interactive Web site that focuses on survivorship, health, and smoking. Participants in the Materials control group will receive tailored and targeted print materials.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00588107
|United States, Massachusetts|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Karen M Emmons, PhD||Dana-Farber Cancer Institute|